• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管内皮生长因子依赖性胎盘生长因子在调节血管生成和肿瘤生长中的时空双重作用。

Vascular endothelial growth factor-dependent spatiotemporal dual roles of placental growth factor in modulation of angiogenesis and tumor growth.

机构信息

Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, 171 77 Stockholm, Sweden.

出版信息

Proc Natl Acad Sci U S A. 2013 Aug 20;110(34):13932-7. doi: 10.1073/pnas.1309629110. Epub 2013 Aug 5.

DOI:10.1073/pnas.1309629110
PMID:23918367
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3752238/
Abstract

Placental growth factor (PlGF) remodels tumor vasculatures toward a normalized phenotype, which affects tumor growth, invasion and drug responses. However, the coordinative and spatiotemporal relation between PlGF and VEGF in modulation of tumor angiogenesis and vascular remodeling is less understood. Here we report that PlGF positively and negatively modulate tumor growth, angiogenesis, and vascular remodeling through a VEGF-dependent mechanism. In two independent tumor models, we show that PlGF inhibited tumor growth and angiogenesis and displayed a marked vascular remodeling effect, leading to normalized microvessels with infrequent vascular branches and increased perivascular cell coverage. Surprisingly, elimination of VEGF gene (i.e., VEGF-null) in PlGF-expressing tumors resulted in (i) accelerated tumor growth rates and angiogenesis and (ii) complete attenuation of PlGF-induced vascular normalization. Thus, PlGF positively and negatively modulates tumor growth, angiogenesis, and vascular remodeling through VEGF-dependent spatiotemporal mechanisms. Our data uncover molecular mechanisms underlying the complex interplay between PlGF and VEGF in modulation of tumor growth and angiogenesis, and have conceptual implication for antiangiogenic cancer therapy.

摘要

胎盘生长因子(PlGF)重塑肿瘤血管,使其向正常表型发展,从而影响肿瘤生长、侵袭和药物反应。然而,PlGF 和 VEGF 之间在调节肿瘤血管生成和血管重塑方面的协调和时空关系还不太清楚。在这里,我们报告 PlGF 通过 VEGF 依赖性机制正向和负向调节肿瘤生长、血管生成和血管重塑。在两个独立的肿瘤模型中,我们表明 PlGF 抑制肿瘤生长和血管生成,并显示出明显的血管重塑作用,导致正常化的微血管,血管分支较少,周细胞覆盖增加。令人惊讶的是,消除 PlGF 表达肿瘤中的 VEGF 基因(即 VEGF 缺失)导致(i)肿瘤生长速度和血管生成加快,以及(ii)PlGF 诱导的血管正常化完全减弱。因此,PlGF 通过 VEGF 依赖性时空机制正向和负向调节肿瘤生长、血管生成和血管重塑。我们的数据揭示了 PlGF 和 VEGF 之间在调节肿瘤生长和血管生成方面的复杂相互作用的分子机制,并为抗血管生成癌症治疗提供了概念上的启示。

相似文献

1
Vascular endothelial growth factor-dependent spatiotemporal dual roles of placental growth factor in modulation of angiogenesis and tumor growth.血管内皮生长因子依赖性胎盘生长因子在调节血管生成和肿瘤生长中的时空双重作用。
Proc Natl Acad Sci U S A. 2013 Aug 20;110(34):13932-7. doi: 10.1073/pnas.1309629110. Epub 2013 Aug 5.
2
Tumor cell-derived placental growth factor sensitizes antiangiogenic and antitumor effects of anti-VEGF drugs.肿瘤细胞衍生的胎盘生长因子增强了抗血管内皮生长因子药物的抗血管生成和抗肿瘤作用。
Proc Natl Acad Sci U S A. 2013 Jan 8;110(2):654-9. doi: 10.1073/pnas.1209310110. Epub 2012 Dec 24.
3
Placental growth factor upregulation is a host response to antiangiogenic therapy.胎盘生长因子上调是宿主对抗血管生成治疗的反应。
Clin Cancer Res. 2011 Mar 1;17(5):976-88. doi: 10.1158/1078-0432.CCR-10-2687. Epub 2011 Feb 22.
4
Placental growth factor-1 attenuates vascular endothelial growth factor-A-dependent tumor angiogenesis during beta cell carcinogenesis.胎盘生长因子-1在β细胞癌变过程中减弱血管内皮生长因子-A依赖性肿瘤血管生成。
Cancer Res. 2007 Nov 15;67(22):10840-8. doi: 10.1158/0008-5472.CAN-07-1034.
5
Placenta growth factor-1 antagonizes VEGF-induced angiogenesis and tumor growth by the formation of functionally inactive PlGF-1/VEGF heterodimers.胎盘生长因子-1通过形成功能失活的PlGF-1/VEGF异二聚体来拮抗VEGF诱导的血管生成和肿瘤生长。
Cancer Cell. 2002 Feb;1(1):99-108. doi: 10.1016/s1535-6108(02)00028-4.
6
Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions.血管内皮生长因子与胎盘生长因子之间的协同作用在病理状态下有助于血管生成和血浆外渗。
Nat Med. 2001 May;7(5):575-83. doi: 10.1038/87904.
7
Heterodimers of placenta growth factor/vascular endothelial growth factor. Endothelial activity, tumor cell expression, and high affinity binding to Flk-1/KDR.胎盘生长因子/血管内皮生长因子异二聚体。内皮细胞活性、肿瘤细胞表达以及与Flk-1/KDR的高亲和力结合。
J Biol Chem. 1996 Feb 9;271(6):3154-62. doi: 10.1074/jbc.271.6.3154.
8
PlGF and VEGF-A Regulate Growth of High-Risk MYCN-Single Copy Neuroblastoma Xenografts via Different Mechanisms.胎盘生长因子(PlGF)和血管内皮生长因子-A(VEGF-A)通过不同机制调节高危MYCN单拷贝神经母细胞瘤异种移植瘤的生长。
Int J Mol Sci. 2016 Sep 23;17(10):1613. doi: 10.3390/ijms17101613.
9
Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization.胎盘生长因子是血管内皮生长因子(VEGF)家族的一员,它有助于脉络膜新生血管的形成。
Invest Ophthalmol Vis Sci. 2003 Jul;44(7):3186-93. doi: 10.1167/iovs.02-1092.
10
Altered tumor vessel maturation and proliferation in placenta growth factor-producing tumors: potential relationship to post-therapy tumor angiogenesis and recurrence.产生胎盘生长因子的肿瘤中肿瘤血管成熟和增殖的改变:与治疗后肿瘤血管生成及复发的潜在关系。
Int J Cancer. 2003 Jun 10;105(2):158-64. doi: 10.1002/ijc.11059.

引用本文的文献

1
Impact of ligand binding on VEGFR1, VEGFR2, and NRP1 localization in human endothelial cells.配体结合对人内皮细胞中VEGFR1、VEGFR2和NRP1定位的影响。
PLoS Comput Biol. 2025 Jul 16;21(7):e1013254. doi: 10.1371/journal.pcbi.1013254. eCollection 2025 Jul.
2
Inhibition of retinal neovascularization by Dendrobium polysaccharides: a review.石斛多糖对视网膜新生血管形成的抑制作用:综述
Front Pharmacol. 2025 Jun 30;16:1584553. doi: 10.3389/fphar.2025.1584553. eCollection 2025.
3
Potential predictive value of CD8A and PGF protein expression in gastric cancer patients treated with neoadjuvant immunotherapy.CD8A和PGF蛋白表达在接受新辅助免疫治疗的胃癌患者中的潜在预测价值。
BMC Cancer. 2025 Apr 12;25(1):674. doi: 10.1186/s12885-025-14046-7.
4
Analysis of the aqueous humor before and after the administration of faricimab in patients with nAMD.在湿性年龄相关性黄斑变性(nAMD)患者中,分析玻璃体内注射faricimab前后的房水情况。
Sci Rep. 2024 Dec 30;14(1):31951. doi: 10.1038/s41598-024-83473-6.
5
Design, synthesis and biological evaluation of VEGFR-2/HDAC dual inhibitors as multitargeted antitumor agents based on fruquintinib and vorinostat.基于呋喹替尼和伏立诺他的VEGFR-2/HDAC双重抑制剂作为多靶点抗肿瘤药物的设计、合成及生物学评价
RSC Adv. 2023 Sep 27;13(41):28462-28480. doi: 10.1039/d3ra05542f. eCollection 2023 Sep 26.
6
Role of Cytokines and Chemokines in Angiogenesis in a Tumor Context.细胞因子和趋化因子在肿瘤环境中血管生成中的作用。
Cancers (Basel). 2022 May 16;14(10):2446. doi: 10.3390/cancers14102446.
7
Evaluation of antitumor effects of VEGFR-2 inhibitor F16 in a colorectal xenograft model.VEGFR-2抑制剂F16在结直肠癌异种移植模型中的抗肿瘤作用评估。
Biotechnol Lett. 2022 Jun;44(5-6):787-801. doi: 10.1007/s10529-022-03243-0. Epub 2022 Apr 30.
8
Release of basic fibroblast growth factor from acoustically-responsive scaffolds promotes therapeutic angiogenesis in the hind limb ischemia model.声响应支架释放碱性成纤维细胞生长因子促进后肢缺血模型中的治疗性血管生成。
J Control Release. 2021 Oct 10;338:773-783. doi: 10.1016/j.jconrel.2021.09.013. Epub 2021 Sep 14.
9
VEGFR1 signaling in retinal angiogenesis and microinflammation.VEGFR1 信号在视网膜血管生成和微炎症中的作用。
Prog Retin Eye Res. 2021 Sep;84:100954. doi: 10.1016/j.preteyeres.2021.100954. Epub 2021 Feb 25.
10
Capillary Rarefaction in Obesity and Metabolic Diseases-Organ-Specificity and Possible Mechanisms.肥胖与代谢性疾病中的毛细血管稀疏——器官特异性及可能机制
Cells. 2020 Dec 14;9(12):2683. doi: 10.3390/cells9122683.

本文引用的文献

1
Tumor cell-derived placental growth factor sensitizes antiangiogenic and antitumor effects of anti-VEGF drugs.肿瘤细胞衍生的胎盘生长因子增强了抗血管内皮生长因子药物的抗血管生成和抗肿瘤作用。
Proc Natl Acad Sci U S A. 2013 Jan 8;110(2):654-9. doi: 10.1073/pnas.1209310110. Epub 2012 Dec 24.
2
Anti-invasive adjuvant therapy with imipramine blue enhances chemotherapeutic efficacy against glioma.使用丙咪嗪蓝进行抗侵袭辅助治疗可增强胶质母细胞瘤的化疗疗效。
Sci Transl Med. 2012 Mar 28;4(127):127ra36. doi: 10.1126/scitranslmed.3003016.
3
Forty-year journey of angiogenesis translational research.血管生成转化研究的四十年历程。
Sci Transl Med. 2011 Dec 21;3(114):114rv3. doi: 10.1126/scitranslmed.3003149.
4
HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF.HRG 通过下调 PlGF 诱导巨噬细胞极化和血管正常化来抑制肿瘤生长和转移。
Cancer Cell. 2011 Jan 18;19(1):31-44. doi: 10.1016/j.ccr.2010.11.009. Epub 2011 Jan 6.
5
PlGF blockade does not inhibit angiogenesis during primary tumor growth.PlGF 阻断并不抑制原发性肿瘤生长过程中的血管生成。
Cell. 2010 Apr 2;141(1):166-77. doi: 10.1016/j.cell.2010.01.033.
6
VEGFR1-mediated pericyte ablation links VEGF and PlGF to cancer-associated retinopathy.VEGFR1 介导体细胞消融将 VEGF 和 PlGF 与癌症相关的视网膜病变联系起来。
Proc Natl Acad Sci U S A. 2010 Jan 12;107(2):856-61. doi: 10.1073/pnas.0911661107. Epub 2009 Dec 22.
7
Malignant cell-derived PlGF promotes normalization and remodeling of the tumor vasculature.恶性细胞衍生的胎盘生长因子促进肿瘤血管的正常化和重塑。
Proc Natl Acad Sci U S A. 2009 Oct 13;106(41):17505-10. doi: 10.1073/pnas.0908026106. Epub 2009 Sep 25.
8
Fulvene-5 potently inhibits NADPH oxidase 4 and blocks the growth of endothelial tumors in mice.富烯-5能有效抑制NADPH氧化酶4,并阻断小鼠体内内皮肿瘤的生长。
J Clin Invest. 2009 Aug;119(8):2359-65. doi: 10.1172/JCI33877. Epub 2009 Jul 13.
9
Improvement of antiangiogenic cancer therapy by understanding the mechanisms of angiogenic factor interplay and drug resistance.通过了解血管生成因子相互作用和耐药性的机制来改善抗血管生成癌症治疗。
Semin Cancer Biol. 2009 Oct;19(5):338-43. doi: 10.1016/j.semcancer.2009.05.001. Epub 2009 May 27.
10
Tumor angiogenesis and molecular targets for therapy.肿瘤血管生成与治疗的分子靶点
Front Biosci (Landmark Ed). 2009 Jan 1;14(10):3962-73. doi: 10.2741/3504.